Lactate as a predictive biomarker and therapeutic target in cardiopulmonary bypass-associated acute kidney injury.

Authors

Dinghao Xue, Mingru Zhang, Xinlu Chang, Tianlong Wang, Bingyang Ji, Chunhua Xi, Guyan Wang

Published in

iScience. Volume 29. Issue 11. Pages 117643. Nov 20, 2026. Epub Oct 08, 2026.

Abstract

Elevated lactate is a common metabolic perturbation following cardiopulmonary bypass (CPB). This study evaluates the clinical predictive value of lactate and explores its mechanism involving protein lactylation. Machine learning (ML) algorithms applied to multicenter intensive care databases identified preoperative lactate as a dominant predictor of CPB-acute kidney injury (AKI) risk. To validate these predictions biologically, rat CPB and cellular models were utilized. Experimental results demonstrated that CPB induces glycolytic reprogramming, lactate accumulation, and elevated pan-lysine lactylation. Inhibiting the production of lactate was associated with decreased protein lactylation, lower oxidative stress, and reduced local tissue inflammation, thereby mitigating renal injury. Collectively, our interpretable ML predictive models identify lactate as a top clinical predictor of CPB-AKI, while our experimental data establish the lactate-lactylation axis as a potential mechanistic pathway linking metabolic dysfunction to renal damage. This axis represents a candidate therapeutic target requiring further validation.

PMID:
42894613
Bibliographic data and abstract were imported from PubMed on 19 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.